ESR1 and breast carcinoma: Previous studies have identified a negative correlation between ER expression in breast carcinoma cells and the intratumoral infiltration of lymphocytes, notably CD4+ T cells, CD8+ T cells, B cells, and tumor-associated macrophages (TAMs).